Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › β-catenin and B-cell lymphoma 9 (BCL9) inhibitors

β-catenin and B-cell lymphoma 9 (BCL9) inhibitors

US Patent 12162856 · Granted Dec 10, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

B-catenin/B-cell Lymphoma 9 protein-protein interaction inhibiting peptidomimeti2025
Small molecule pyrin-domain targeted NLRP3 inflammasome inhibitors2025
Methods and compositions of 4-substituted benzoylpiperazine-1-substituted carbon2025
Peptidomimetic inhibitors of β-catenin/Tcf protein-protein interaction2025
Underwater robot for mine flooding rescue2025
Stapled H2 pyrin peptides2024
Inhibitors for the B-catenin/B-cell lymphoma 9 (BCL9) protein-protein interactio2024
Real-time localization error correction of autonomous vehicle2023
Inhibitors for the B-catenin/B-cell lymphoma 9 (BCL9) protein-protein interactio2023
Methods and composition of 4-substituted benzoylpiperazine-1-substituted carbony2023
Inhibitors for the β-catenin / T-cell factor protein-protein interaction2022
Network interface controller with non-volatile random access memory write packet2022